HEADER TRANSFERASE 09-JUN-10 2XH5 TITLE STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2,3-D) TITLE 2 PYRIMIDIN-4-YL)PIPERIDIN-4-AMINE BOUND TO PKB COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-BETA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE CATALYTIC DOMAIN, RESIDUES 146-467; COMPND 5 SYNONYM: RAC-PK-BETA, PROTEIN KINASE AKT-2, PROTEIN KINASE B\,BETA, COMPND 6 PKB BETA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: PIFTIDE SEQUENCE (EEQEMFEDFDYIADW) REPLACES NATURAL COMPND 11 PKB SEQUENCE AFTER RESIDUE 464C; COMPND 12 MOL_ID: 2; COMPND 13 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 14 CHAIN: C; COMPND 15 FRAGMENT: RESIDUES 3-12; COMPND 16 SYNONYM: GSK-3 BETA, GSK-3 BETA; COMPND 17 EC: 2.7.11.26; COMPND 18 OTHER_DETAILS: PEPTIDE DERIVED FROM THE KINASE GSK3-BETA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606 KEYWDS SERINE/THREONINE-PROTEIN KINASE, NUCLEOTIDE-BINDING, WNT SIGNALING KEYWDS 2 PATHWAY, KINASE, TRANSFERASE, PHOSPHOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.G.DAVIES,T.MCHARDY,J.J.CALDWELL,K.M.CHEUNG,L.J.HUNTER,K.TAYLOR, AUTHOR 2 M.ROWLANDS,R.RUDDLE,A.HENLEY,A.D.BRANDON,M.VALENTI,L.FAZAL, AUTHOR 3 L.SEAVERS,F.I.RAYNAUD,S.A.ECCLES,G.W.AHERNE,M.D.GARRETT,I.COLLINS REVDAT 1 16-JUN-10 2XH5 0 SPRSDE 16-JUN-10 2XH5 2X37 JRNL AUTH T.MCHARDY,J.J.CALDWELL,K.M.CHEUNG,L.J.HUNTER,K.TAYLOR, JRNL AUTH 2 M.ROWLANDS,R.RUDDLE,A.HENLEY,A.DE HAVEN BRANDON,M.VALENTI, JRNL AUTH 3 T.G.DAVIES,L.FAZAL,L.SEAVERS,F.I.RAYNAUD,S.A.ECCLES, JRNL AUTH 4 G.W.AHERNE,M.D.GARRETT,I.COLLINS JRNL TITL DISCOVERY OF 4-AMINO-1-(7H-PYRROLO[2,3-D]PYRIMIDIN- JRNL TITL 2 4-YL)PIPERIDINE-4-CARBOXAMIDES AS SELECTIVE, ORALLY ACTIVE JRNL TITL 3 INHIBITORS OF PROTEIN KINASE B (AKT). JRNL REF J.MED.CHEM. V. 53 2239 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20151677 JRNL DOI 10.1021/JM901788J REMARK 2 REMARK 2 RESOLUTION. 2.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0062 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 97.52 REMARK 3 NUMBER OF REFLECTIONS : 9800 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.21574 REMARK 3 R VALUE (WORKING SET) : 0.21133 REMARK 3 FREE R VALUE : 0.30537 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.8 REMARK 3 FREE R VALUE TEST SET COUNT : 492 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.724 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.795 REMARK 3 REFLECTION IN BIN (WORKING SET) : 682 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.37 REMARK 3 BIN R VALUE (WORKING SET) : 0.275 REMARK 3 BIN FREE R VALUE SET COUNT : 32 REMARK 3 BIN FREE R VALUE : 0.378 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2659 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 44 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.411 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.44 REMARK 3 B22 (A**2) : 3.56 REMARK 3 B33 (A**2) : -3.11 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.451 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.311 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.523 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.833 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2761 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1940 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3728 ; 1.438 ; 1.960 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4677 ; 0.893 ; 2.975 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 326 ; 6.668 ; 5.092 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;35.378 ;23.059 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 490 ;17.325 ;15.041 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;16.494 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 393 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3030 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 610 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 146 A 231 REMARK 3 ORIGIN FOR THE GROUP (A): 39.8704 37.9150 106.9277 REMARK 3 T TENSOR REMARK 3 T11: 0.1373 T22: 0.1266 REMARK 3 T33: 0.0956 T12: -0.0032 REMARK 3 T13: -0.0032 T23: 0.0410 REMARK 3 L TENSOR REMARK 3 L11: 2.0345 L22: 2.4650 REMARK 3 L33: 2.9434 L12: 0.1747 REMARK 3 L13: -0.8696 L23: 0.6844 REMARK 3 S TENSOR REMARK 3 S11: -0.0488 S12: 0.4488 S13: 0.1166 REMARK 3 S21: -0.3337 S22: 0.0186 S23: 0.1792 REMARK 3 S31: 0.0454 S32: -0.0978 S33: 0.0302 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 3 C 12 REMARK 3 RESIDUE RANGE : A 232 A 479 REMARK 3 ORIGIN FOR THE GROUP (A): 37.5169 29.8977 127.6584 REMARK 3 T TENSOR REMARK 3 T11: 0.0175 T22: 0.0369 REMARK 3 T33: 0.0636 T12: 0.0194 REMARK 3 T13: -0.0009 T23: -0.0260 REMARK 3 L TENSOR REMARK 3 L11: 2.5698 L22: 2.4444 REMARK 3 L33: 2.0152 L12: 0.1895 REMARK 3 L13: -0.0882 L23: -0.7931 REMARK 3 S TENSOR REMARK 3 S11: -0.0124 S12: 0.0213 S13: 0.0120 REMARK 3 S21: -0.0613 S22: 0.0152 S23: -0.0196 REMARK 3 S31: -0.0365 S32: -0.0058 S33: -0.0028 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2XH5 COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-JUN-10. REMARK 100 THE PDBE ID CODE IS EBI-44195. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07230 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10369 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.72 REMARK 200 RESOLUTION RANGE LOW (A) : 55.80 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 2.2 REMARK 200 R MERGE (I) : 0.10 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.90 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.47400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.83550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.61650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.83550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.47400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.61650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 141 REMARK 465 ALA A 142 REMARK 465 MET A 143 REMARK 465 ASP A 144 REMARK 465 PRO A 145 REMARK 465 ILE A 450 REMARK 465 THR A 451 REMARK 465 PRO A 452 REMARK 465 PRO A 453 REMARK 465 ASP A 454 REMARK 465 ARG A 455 REMARK 465 TYR A 456 REMARK 465 ASP A 457 REMARK 465 SER A 458 REMARK 465 LEU A 459 REMARK 465 GLY A 460 REMARK 465 LEU A 461 REMARK 465 LEU A 462 REMARK 465 GLU A 463 REMARK 465 LEU A 464 REMARK 465 ASP A 464A REMARK 465 GLN A 464B REMARK 465 ARG A 464C REMARK 465 GLU A 465 REMARK 465 GLU A 466 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 449 OG1 CG2 REMARK 470 GLN A 467 CG CD OE1 NE2 REMARK 470 GLU A 468 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 221 -165.23 -111.10 REMARK 500 ARG A 245 -38.71 77.05 REMARK 500 ASP A 275 53.11 -148.25 REMARK 500 ASP A 293 108.72 66.53 REMARK 500 ASP A 303 -117.81 49.05 REMARK 500 ASN A 325 -167.79 72.35 REMARK 500 ASP A 399 -120.45 63.88 REMARK 500 GLN A 429 74.17 -100.22 REMARK 500 THR A 431 -71.81 -73.87 REMARK 500 GLU A 468 -84.13 70.66 REMARK 500 PHE A 473 -56.61 -136.34 REMARK 500 ARG C 4 133.82 55.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X37 A1480 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2UW9 RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH REMARK 900 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4 REMARK 900 -YL)-PHENYL)-PIPERIDINE REMARK 900 RELATED ID: 1O6K RELATED DB: PDB REMARK 900 STRUCTURE OF ACTIVATED FORM OF PKB KINASE REMARK 900 DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP REMARK 900 RELATED ID: 1GNG RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE 3BETA (GSK3) COMPLEX WITH REMARK 900 FRATTIDE PEPTIDE REMARK 900 RELATED ID: 1H8F RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA. REMARK 900 RELATED ID: 1Q3W RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE REMARK 900 RELATED ID: 1GZO RELATED DB: PDB REMARK 900 STRUCTURE OF PROTEIN KINASE B UNPHOSPHORYLATED REMARK 900 RELATED ID: 1I09 RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 ( REMARK 900 GSK3B) REMARK 900 RELATED ID: 1O9U RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED REMARK 900 WITH AXIN PEPTIDE REMARK 900 RELATED ID: 1O6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVATED AKT/ REMARK 900 PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY REMARK 900 COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE REMARK 900 RELATED ID: 2JDR RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH REMARK 900 THE INHIBITOR A-443654 REMARK 900 RELATED ID: 1J1B RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU REMARK 900 PROTEIN KINASE I WITHAMPPNP REMARK 900 RELATED ID: 1GZK RELATED DB: PDB REMARK 900 MOLECULAR MECHANISM FOR THE REGULATION OF REMARK 900 PROTEIN KINASE B/AKT BY HYDROPHOBIC MOTIF REMARK 900 PHOSPHORYLATION REMARK 900 RELATED ID: 1R0E RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX REMARK 900 WITH 3-INDOLYL-4-ARYLMALEIMIDE INHIBITOR REMARK 900 RELATED ID: 1Q41 RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'- REMARK 900 MONOXIME REMARK 900 RELATED ID: 2X39 RELATED DB: PDB REMARK 900 STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1 REMARK 900 -(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL) REMARK 900 PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB REMARK 900 RELATED ID: 1MRV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE REMARK 900 DOMAIN REMARK 900 RELATED ID: 2JLD RELATED DB: PDB REMARK 900 EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX REMARK 900 TO GLYCOGEN SYNTHASE KINASE 3 REMARK 900 RELATED ID: 1Q3D RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH STAUROSPORINE REMARK 900 RELATED ID: 1GZN RELATED DB: PDB REMARK 900 STRUCTURE OF PKB KINASE DOMAIN REMARK 900 RELATED ID: 1Q5K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE REMARK 900 3 INCOMPLEXED WITH INHIBITOR REMARK 900 RELATED ID: 2JDO RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH REMARK 900 ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4- REMARK 900 CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE REMARK 900 RELATED ID: 1PYX RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH AMP-PNP REMARK 900 RELATED ID: 1MRY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE REMARK 900 DOMAIN REMARK 900 RELATED ID: 1Q4L RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INHIBITOR I-5 REMARK 900 RELATED ID: 1UV5 RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED REMARK 900 WITH 6-BROMOINDIRUBIN-3'-OXIME REMARK 900 RELATED ID: 1J1C RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU REMARK 900 PROTEIN KINASE I WITHADP REMARK 900 RELATED ID: 1P6S RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY REMARK 900 DOMAIN OFHUMAN PROTEIN KINASE B BETA (PKB REMARK 900 /AKT) REMARK 999 REMARK 999 SEQUENCE REMARK 999 CLONE DOES NOT CONTAIN THE FIRST 145 RESIDUES OF THE REMARK 999 P31751 SEQUENCE (PH-DOMAIN). RESIDUES GAMDP AT THE START REMARK 999 OF THE CLONED SEQUENCE ARE ARTEFACTS FROM A PURIFICATION REMARK 999 TAG, HOWEVER THESE ARE NOT VISIBLE IN THE STRUCTURE AND REMARK 999 WERE NOT BUILT. THE CLONE CONTAINS THE SEQUENCE REMARK 999 EEQEMFEDFDYIADW (PIFTIDE) INSTEAD OF THE P31751 SEQUENCE REMARK 999 FROM POSITION 465 ONWARDS. RESIDUES 450 - 466 ARE REMARK 999 DISORDERED AND HAVE NOT BEEN BUILT IN THE STRUCTURE. DBREF 2XH5 A 146 479 UNP P31751 AKT2_HUMAN 146 479 DBREF 2XH5 C 3 12 UNP P49841 GSK3B_HUMAN 3 12 SEQADV 2XH5 GLY A 141 UNP P31751 EXPRESSION TAG SEQADV 2XH5 ALA A 142 UNP P31751 EXPRESSION TAG SEQADV 2XH5 MET A 143 UNP P31751 EXPRESSION TAG SEQADV 2XH5 ASP A 144 UNP P31751 EXPRESSION TAG SEQADV 2XH5 PRO A 145 UNP P31751 EXPRESSION TAG SEQADV 2XH5 ARG A 464C UNP P31751 INSERTION SEQADV 2XH5 GLU A 465 UNP P31751 INSERTION SEQADV 2XH5 GLU A 466 UNP P31751 INSERTION SEQADV 2XH5 GLN A 467 UNP P31751 ARG 467 ENGINEERED MUTATION SEQADV 2XH5 GLU A 468 UNP P31751 THR 468 ENGINEERED MUTATION SEQADV 2XH5 MET A 469 UNP P31751 HIS 469 ENGINEERED MUTATION SEQADV 2XH5 GLU A 471 UNP P31751 PRO 471 ENGINEERED MUTATION SEQADV 2XH5 ASP A 472 UNP P31751 GLN 472 ENGINEERED MUTATION SEQADV 2XH5 ASP A 474 UNP P31751 SER 474 ENGINEERED MUTATION SEQADV 2XH5 ILE A 476 UNP P31751 SER 476 ENGINEERED MUTATION SEQADV 2XH5 ASP A 478 UNP P31751 SER 478 ENGINEERED MUTATION SEQADV 2XH5 TRP A 479 UNP P31751 ILE 479 ENGINEERED MUTATION SEQRES 1 A 342 GLY ALA MET ASP PRO LYS VAL THR MET ASN ASP PHE ASP SEQRES 2 A 342 TYR LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL SEQRES 3 A 342 ILE LEU VAL ARG GLU LYS ALA THR GLY ARG TYR TYR ALA SEQRES 4 A 342 MET LYS ILE LEU ARG LYS GLU VAL ILE ILE ALA LYS ASP SEQRES 5 A 342 GLU VAL ALA HIS THR VAL THR GLU SER ARG VAL LEU GLN SEQRES 6 A 342 ASN THR ARG HIS PRO PHE LEU THR ALA LEU LYS TYR ALA SEQRES 7 A 342 PHE GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR SEQRES 8 A 342 ALA ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU SEQRES 9 A 342 ARG VAL PHE THR GLU GLU ARG ALA ARG PHE TYR GLY ALA SEQRES 10 A 342 GLU ILE VAL SER ALA LEU GLU TYR LEU HIS SER ARG ASP SEQRES 11 A 342 VAL VAL TYR ARG ASP ILE LYS LEU GLU ASN LEU MET LEU SEQRES 12 A 342 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 A 342 CYS LYS GLU GLY ILE SER ASP GLY ALA THR MET LYS TPO SEQRES 14 A 342 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 A 342 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 A 342 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 A 342 PRO PHE TYR ASN GLN ASP HIS GLU ARG LEU PHE GLU LEU SEQRES 18 A 342 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU SER SEQRES 19 A 342 PRO GLU ALA LYS SER LEU LEU ALA GLY LEU LEU LYS LYS SEQRES 20 A 342 ASP PRO LYS GLN ARG LEU GLY GLY GLY PRO SER ASP ALA SEQRES 21 A 342 LYS GLU VAL MET GLU HIS ARG PHE PHE LEU SER ILE ASN SEQRES 22 A 342 TRP GLN ASP VAL VAL GLN LYS LYS LEU LEU PRO PRO PHE SEQRES 23 A 342 LYS PRO GLN VAL THR SER GLU VAL ASP THR ARG TYR PHE SEQRES 24 A 342 ASP ASP GLU PHE THR ALA GLN SER ILE THR ILE THR PRO SEQRES 25 A 342 PRO ASP ARG TYR ASP SER LEU GLY LEU LEU GLU LEU ASP SEQRES 26 A 342 GLN ARG GLU GLU GLN GLU MET PHE GLU ASP PHE ASP TYR SEQRES 27 A 342 ILE ALA ASP TRP SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 2XH5 TPO A 309 THR PHOSPHOTHREONINE HET X37 A1480 57 HET TPO A 309 11 HETNAM X37 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO[2,3-D] HETNAM 2 X37 PYRIMIDIN-4-YL)PIPERIDIN-4-AMINIUM HETNAM TPO PHOSPHOTHREONINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 3 X37 C22 H30 N5 1+ FORMUL 4 TPO C4 H10 N O6 P FORMUL 5 HOH *44(H2 O) HELIX 1 1 THR A 148 ASN A 150 5 3 HELIX 2 2 LYS A 185 LYS A 191 1 7 HELIX 3 3 GLU A 193 ASN A 206 1 14 HELIX 4 4 GLU A 236 ARG A 245 1 10 HELIX 5 5 THR A 248 ARG A 269 1 22 HELIX 6 6 THR A 313 LEU A 317 5 5 HELIX 7 7 ALA A 318 LEU A 322 5 5 HELIX 8 8 ALA A 330 GLY A 346 1 17 HELIX 9 9 ASP A 354 GLU A 365 1 12 HELIX 10 10 SER A 374 LEU A 385 1 12 HELIX 11 11 ASP A 388 ARG A 392 5 5 HELIX 12 12 ASP A 399 GLU A 405 1 7 HELIX 13 13 HIS A 406 LEU A 410 5 5 HELIX 14 14 TRP A 414 GLN A 419 1 6 HELIX 15 15 ASP A 440 ALA A 445 1 6 SHEET 1 AA 6 PHE A 152 GLY A 161 0 SHEET 2 AA 6 GLY A 164 GLU A 171 -1 O GLY A 164 N GLY A 161 SHEET 3 AA 6 TYR A 177 ARG A 184 -1 O TYR A 178 N VAL A 169 SHEET 4 AA 6 ARG A 224 GLU A 230 -1 O LEU A 225 N LEU A 183 SHEET 5 AA 6 LEU A 215 GLN A 220 -1 N LYS A 216 O VAL A 228 SHEET 6 AA 6 TYR A 475 ILE A 476 -1 O TYR A 475 N ALA A 218 SHEET 1 AB 2 LEU A 281 LEU A 283 0 SHEET 2 AB 2 ILE A 289 ILE A 291 -1 O LYS A 290 N MET A 282 SHEET 1 AC 2 CYS A 311 GLY A 312 0 SHEET 2 AC 2 PHE C 10 ALA C 11 -1 O PHE C 10 N GLY A 312 LINK C LYS A 308 N TPO A 309 1555 1555 1.32 LINK C TPO A 309 N PHE A 310 1555 1555 1.32 SITE 1 AC1 16 LYS A 160 GLY A 161 GLY A 164 VAL A 166 SITE 2 AC1 16 ALA A 179 LYS A 181 MET A 229 GLU A 230 SITE 3 AC1 16 ALA A 232 GLU A 236 GLU A 279 MET A 282 SITE 4 AC1 16 THR A 292 ASP A 293 PHE A 439 ARG C 6 CRYST1 44.948 61.233 135.671 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022248 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016331 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007371 0.00000